HealthcareServices

Biopharmaceutical CMO Market 2026–2030: Forecast, Innovation, and Competitive Trends

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biopharmaceutical cmo market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Biopharmaceutical CMO Market show for the 2026–2030 period?

The biopharmaceutical cmo market has witnessed rapid growth in recent years. Its value is anticipated to rise from $28.02 billion in 2025 to $32.03 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. Historically, this expansion has been driven by increasing biologics pipeline development, a surge in clinical trial activity, escalating demand for flexible manufacturing capacity, a rise in biosimilar approvals, and the availability of specialized biomanufacturing expertise.

The biopharmaceutical cmo market is poised for significant expansion in the coming years. Its size is expected to escalate to $54.54 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This projected growth during the forecast period stems from factors such as increasing investments in advanced biologics, a rising demand for swift scale-up manufacturing, the broadening of personalized therapies, a growing embrace of continuous bioprocessing, and an enhanced focus on risk-sharing manufacturing models. Noteworthy trends for the forecast period include a surge in the outsourcing of biologics manufacturing, increased demand for biosimilar production services, the wider adoption of single-use bioprocessing systems, the expansion of cell and gene therapy manufacturing, and a stronger emphasis on comprehensive end-to-end cmo capabilities.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7771&type=smp

What Drivers Are Shaping The Development Of The Biopharmaceutical CMO Market?

The escalating prevalence of chronic conditions is anticipated to fuel expansion within the biopharmaceutical CMO market in the future. These are enduring health issues that last a lifetime, typically advancing gradually and necessitating continuous medical care. Biopharmaceutical CMOs play a crucial role in combating chronic illnesses by accelerating drug creation, providing economical manufacturing, and upholding stringent quality benchmarks, consequently boosting the availability and affordability of vital treatments. For example, in January 2024, the World Health Organization, an intergovernmental entity based in Switzerland, indicated that the load of noncommunicable diseases, predominantly cardiovascular disease, cancer, chronic respiratory disease, and diabetes, is still on the rise, causing 41 million people to die annually. This accounts for 74% of all deaths and a significant portion of early mortality globally, disproportionately affecting low- and middle-income nations. Hence, the rising incidence of chronic diseases is a key factor propelling the biopharmaceutical CMOs market.

Which Segments Are Contributing To The Growth Of The Biopharmaceutical CMO Market?

The biopharmaceutical cmo market covered in this report is segmented –

1) By Product: Biologics, Biosimilars

2) By Source: Mammalian, Non-Mammalian

3) By Service: Manufacturing, Fill And Finish Operations, Analytical And QC Studies, Packaging

Subsegments:

1) By Biologics: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell And Gene Therapies

2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Recombinant Proteins, Biosimilar Insulins, Biosimilar Growth Hormones

What Trends Are Expected To Impact The Competitive Landscape Of The Biopharmaceutical CMO Market?

Leading companies in the biopharmaceutical Contract Manufacturing Organization (CMO) market are embracing strategic collaborations to produce novel biopharmaceutical items. These partnerships aid biopharmaceutical CMO firms by pooling resources and expertise, strengthening research and development proficiencies, broadening market presence, and quickening commercialization, consequently stimulating innovation and expansion within the biopharmaceutical CMO industry. For instance, in May 2024, BioConnection, a Netherlands-based contract manufacturing company, formed an alliance with AGC Biologics, a US-based contract development and manufacturing company. This collaboration aims to offer an optimized, complete solution for biopharmaceutical development and manufacturing, reducing timelines and streamlining operations for drug developers.

Who Are The Top-Performing Companies In The Biopharmaceutical CMO Market In Recent Years?

Major companies operating in the biopharmaceutical cmo market are Lonza Group AG, Fujifilm Diosynth Biotechnologies USA Inc., Thermo Fisher Scientific Inc., Samsung Biologics, WuXi AppTec, Catalent, Inc., Rentschler Biopharma SE, Boehringer Ingelheim, Recipharm AB, AGC Biologics, CMC Biologics, KBI Biopharma, Vetter Pharma International GmbH, Emergent BioSolutions Inc., Aenova Group, Bio-Xcellence (Boehringer Ingelheim), AbbVie Contract Manufacturing, PCI Pharma Services, Evonik Industries AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

Which Region Currently Holds The Largest Share Of The Biopharmaceutical CMO Market?

North America was the largest region in the biopharmaceutical CMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biopharmaceutical CMO Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7771&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical CMO Market 2026, By The Business Research Company

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Medical Biomimetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-biomimetics-global-market-report

Biosimilar Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795